{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:24:54Z","timestamp":1707524694262},"reference-count":37,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,6]]},"DOI":"10.7759\/cureus.31154","type":"journal-article","created":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T12:02:35Z","timestamp":1667736155000},"source":"Crossref","is-referenced-by-count":1,"title":["An Etiological Investigation of Paraneoplastic Cerebellar Degeneration in Ovarian Cancer Patients: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Akbar A","family":"Fidahussain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Abid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Awais A","family":"Paracha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varun E","family":"Jeevan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Rueve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mckimmon","family":"Engelhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cody","family":"Schrock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Ghani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hari K","family":"Nair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Paraneoplastic Syndromes","author":"Thapa B","year":"2022","unstructured":"Thapa B, Mahendraker N, Ramphul K. Paraneoplastic Syndromes. StatPearls Publishing, Treasure Island, FL; 2022."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-016-0058-x","article-title":"Paraneoplastic neurological complications of breast cancer","volume":"5","author":"Fanous I","year":"2015","unstructured":"Fanous I, Dillon P. Paraneoplastic neurological complications of breast cancer. Exp Hematol Oncol. 2015, 5:29. 10.1186\/s40164-016-0058-x","journal-title":"Exp Hematol Oncol"},{"key":"ref3","article-title":"Paraneoplastic Cerebellar Degeneration","author":"Aly R","year":"2022","unstructured":"Aly R, Emmady PD. Paraneoplastic Cerebellar Degeneration. StatPearls Publishing, Treasure Island, FL; 2022."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2017-220544","article-title":"Paraneoplastic cerebellar degeneration secondary to ovarian carcinosarcoma: a cerebellar conundrum","volume":"2017","author":"Birch JD","year":"2017","unstructured":"Birch JD, Sen A, Rowland K, Viner T. Paraneoplastic cerebellar degeneration secondary to ovarian carcinosarcoma: a cerebellar conundrum. BMJ Case Rep. 2017, 2017:3-7. 10.1136\/bcr-2017-220544","journal-title":"BMJ Case Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-014-1745-9","article-title":"Paraneoplastic neurological syndromes associated with ovarian tumors","volume":"141","author":"Zaborowski MP","year":"2015","unstructured":"Zaborowski MP, Spaczynski M, Nowak-Markwitz E, Michalak S. Paraneoplastic neurological syndromes associated with ovarian tumors. J Cancer Res Clin Oncol. 2015, 141:99-108. 10.1007\/s00432-014-1745-9","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.42.10.1931","article-title":"Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients","volume":"42","author":"Peterson K","year":"1992","unstructured":"Peterson K, Rosenblum MK, Kotanides H, Posner JB. Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology. 1992, 42:1931-7. 10.1212\/wnl.42.10.1931","journal-title":"Neurology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2020.100649","article-title":"Potential effect of intravenous immunoglobulin against paraneoplastic cerebellar degeneration in progressive ovarian cancer","volume":"34","author":"Shibata T","year":"2020","unstructured":"Shibata T, Oishi T, Fukuoka Y, Nishikawa S, Iizuka N, Kato H. Potential effect of intravenous immunoglobulin against paraneoplastic cerebellar degeneration in progressive ovarian cancer. Gynecol Oncol Rep. 2020, 34:100649. 10.1016\/j.gore.2020.100649","journal-title":"Gynecol Oncol Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2003.034447","article-title":"Recommended diagnostic criteria for paraneoplastic neurological syndromes","volume":"75","author":"Graus F","year":"2004","unstructured":"Graus F, Delattre JY, Antoine JC, et al.. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004, 75:1135-40. 10.1136\/jnnp.2003.034447","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref9","article-title":"Ovarian Cancer","author":"Arora T","year":"2022","unstructured":"Arora T, Mullangi S, Lekkala MR. Ovarian Cancer. StatPearls Publishing, Treasure Island, FL; 2022."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00639","article-title":"Real-world impact of survival by period of diagnosis in epithelial ovarian cancer between 1990 and 2014","volume":"9","author":"Wu SG","year":"2019","unstructured":"Wu SG, Wang J, Sun JY, He ZY, Zhang WW, Zhou J. Real-world impact of survival by period of diagnosis in epithelial ovarian cancer between 1990 and 2014. Front Oncol. 2019, 9:639. 10.3389\/fonc.2019.00639","journal-title":"Front Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32552-2","article-title":"Epithelial ovarian cancer","volume":"393","author":"Lheureux S","year":"2019","unstructured":"Lheureux S, Gourley C, Vergote I, Oza AM. Epithelial ovarian cancer. Lancet. 2019, 393:1240-53. 10.1016\/S0140-6736(18)32552-2","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/s0025-6196(12)62189-2","article-title":"Gynecologic cancer in patients with subacute cerebellar degeneration predicted by anti-Purkinje cell antibodies and limited in metastatic volume","volume":"65","author":"Hetzel DJ","year":"1990","unstructured":"Hetzel DJ, Stanhope CR, O'Neill BP, Lennon VA. Gynecologic cancer in patients with subacute cerebellar degeneration predicted by anti-Purkinje cell antibodies and limited in metastatic volume. Mayo Clin Proc. 1990, 65:1558-63. 10.1016\/s0025-6196(12)62189-2","journal-title":"Mayo Clin Proc"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher D","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009, 6:e1000097. 10.1371\/journal.pmed.1000097","journal-title":"PLoS Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2016.24.161.6743","article-title":"Paraneoplastic syndromes revealing ovarian teratoma in young and menopausal women: report of two cases","volume":"24","author":"Boujoual M","year":"2016","unstructured":"Boujoual M, Hakimi I, Kassidi F, et al.. Paraneoplastic syndromes revealing ovarian teratoma in young and menopausal women: report of two cases. Pan Afr Med J. 2016, 24:161. 10.11604\/pamj.2016.24.161.6743","journal-title":"Pan Afr Med J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2019-229777","article-title":"Rare case of paraneoplastic cerebellar degeneration secondary to high-grade serous carcinoma of tubo-ovarian origin","volume":"12","author":"Butt E","year":"2019","unstructured":"Butt E, Tadross JA, Chadda KR, Latimer J. Rare case of paraneoplastic cerebellar degeneration secondary to high-grade serous carcinoma of tubo-ovarian origin. BMJ Case Rep. 2019, 12:1-5. 10.1136\/bcr-2019-229777","journal-title":"BMJ Case Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjog.2014.03.012","article-title":"Paraneoplastic cerebellar degeneration in a patient with ovarian cancer","volume":"54","author":"Chien HJ","year":"2015","unstructured":"Chien HJ, Lee CY, Chen LA, Wu CC, Chang CL. Paraneoplastic cerebellar degeneration in a patient with ovarian cancer. Taiwan J Obstet Gynecol. 2015, 54:313-5. 10.1016\/j.tjog.2014.03.012","journal-title":"Taiwan J Obstet Gynecol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000007362","article-title":"Anti-Yo positive and late-onset paraneoplastic cerebellar degeneration associated with ovarian carcinoma: a case report","volume":"96","author":"Cui D","year":"2017","unstructured":"Cui D, Xu L, Li WY, Qian WD. Anti-Yo positive and late-onset paraneoplastic cerebellar degeneration associated with ovarian carcinoma: a case report. Medicine (Baltimore). 2017, 96:e7362. 10.1097\/MD.0000000000007362","journal-title":"Medicine (Baltimore)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000005410","article-title":"Clinical Reasoning: a 60-year-old woman with ataxia","volume":"90","author":"Dandapat S","year":"2018","unstructured":"Dandapat S, Chaku S, Gilchrist J. Clinical Reasoning: a 60-year-old woman with ataxia. Neurology. 2018, 90:e1627-30. 10.1212\/WNL.0000000000005410","journal-title":"Neurology"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2020.100695","article-title":"Paraneoplastic cerebellar degeneration associated with anti-Yo antibodies in an ovarian cancer case: a case report","volume":"35","author":"Deac S","year":"2021","unstructured":"Deac S, Stana MM, Havasi AD, et al.. Paraneoplastic cerebellar degeneration associated with anti-Yo antibodies in an ovarian cancer case: a case report. Gynecol Oncol Rep. 2021, 35:100695. 10.1016\/j.gore.2020.100695","journal-title":"Gynecol Oncol Rep"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s00381-015-2731-5","article-title":"Severe central and peripheral paraneoplastic demyelination associated with tumours of the ovaries","volume":"31","author":"Jurkiewicz E","year":"2015","unstructured":"Jurkiewicz E, Kotulska K, Nowak K, Malczyk K, Borkowska J, Bilska M. Severe central and peripheral paraneoplastic demyelination associated with tumours of the ovaries. Childs Nerv Syst. 2015, 31:1601-6. 10.1007\/s00381-015-2731-5","journal-title":"Childs Nerv Syst"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-021-03779-7","article-title":"Paraneoplastic cerebellar degeneration (PCD) associated with PCA-1 antibodies in established cancer patients","volume":"153","author":"Lehner MJ","year":"2021","unstructured":"Lehner MJ, Gheeya JS, Siddiqui BA, Tummala S. Paraneoplastic cerebellar degeneration (PCD) associated with PCA-1 antibodies in established cancer patients. J Neurooncol. 2021, 153:441-6. 10.1007\/s11060-021-03779-7","journal-title":"J Neurooncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.4103\/0366-6999.166028","article-title":"A rare case of ovarian cancer presenting with paraneoplastic cerebellar degeneration and limbic encephalitis","volume":"128","author":"Li WH","year":"2015","unstructured":"Li WH, Cao DY, Shen K, Yang JX. A rare case of ovarian cancer presenting with paraneoplastic cerebellar degeneration and limbic encephalitis. Chin Med J (Engl). 2015, 128:2685-7. 10.4103\/0366-6999.166028","journal-title":"Chin Med J (Engl)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1159\/000509029","article-title":"Paraneoplastic cerebellar ataxia can affect prognosis in high-grade serous ovarian cancer: a case report","volume":"13","author":"Liapi A","year":"2020","unstructured":"Liapi A, Sarivalasis A. Paraneoplastic cerebellar ataxia can affect prognosis in high-grade serous ovarian cancer: a case report. Case Rep Oncol. 2020, 13:1006-12. 10.1159\/000509029","journal-title":"Case Rep Oncol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4103\/aian.AIAN_411_17","article-title":"Paraneoplastic cerebellar degeneration associated with ovarian adenocarcinoma: a case report and review of literature","volume":"21","author":"Renjen PN","year":"2018","unstructured":"Renjen PN, Chaudhari DM, Shilpi US, Zutshi D, Ahmad K. Paraneoplastic cerebellar degeneration associated with ovarian adenocarcinoma: a case report and review of literature. Ann Indian Acad Neurol. 2018, 21:311-4. 10.4103\/aian.AIAN_411_17","journal-title":"Ann Indian Acad Neurol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2015.1531","article-title":"Non-N-methyl-D-aspartate receptor antibody encephalitis with cerebellitis with associated ovarian teratoma","volume":"72","author":"Smith AD 3rd","year":"2015","unstructured":"Smith AD 3rd, Samkoff L. Non-N-methyl-D-aspartate receptor antibody encephalitis with cerebellitis with associated ovarian teratoma. JAMA Neurol. 2015, 72:1375-7. 10.1001\/jamaneurol.2015.1531","journal-title":"JAMA Neurol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-017-2041-8","article-title":"Cerebellar degeneration-related proteins 2 and 2-like are present in ovarian cancer in patients with and without Yo antibodies","volume":"66","author":"Raspotnig M","year":"2017","unstructured":"Raspotnig M, Haugen M, Thorsteinsdottir M, Stefansson I, Salvesen HB, Storstein A, Vedeler CA. Cerebellar degeneration-related proteins 2 and 2-like are present in ovarian cancer in patients with and without Yo antibodies. Cancer Immunol Immunother. 2017, 66:1463-71. 10.1007\/s00262-017-2041-8","journal-title":"Cancer Immunol Immunother"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-017-1802-y","article-title":"Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration","volume":"135","author":"Small M","year":"2018","unstructured":"Small M, Treilleux I, Couillault C, et al.. Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration. Acta Neuropathol. 2018, 135:569-79. 10.1007\/s00401-017-1802-y","journal-title":"Acta Neuropathol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0125-7","article-title":"Transcriptomic immune profiling of ovarian cancers in paraneoplastic cerebellar degeneration associated with anti-Yo antibodies","volume":"119","author":"Vialatte de P\u00e9mille C","year":"2018","unstructured":"Vialatte de P\u00e9mille C, Berzero G, Small M, et al.. Transcriptomic immune profiling of ovarian cancers in paraneoplastic cerebellar degeneration associated with anti-Yo antibodies. Br J Cancer. 2018, 119:105-13. 10.1038\/s41416-018-0125-7","journal-title":"Br J Cancer"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2017.12.012","article-title":"Complex HLA association in paraneoplastic cerebellar ataxia with anti-Yo antibodies","volume":"315","author":"Hillary RP","year":"2018","unstructured":"Hillary RP, Ollila HM, Lin L, et al.. Complex HLA association in paraneoplastic cerebellar ataxia with anti-Yo antibodies. J Neuroimmunol. 2018, 315:28-32. 10.1016\/j.jneuroim.2017.12.012","journal-title":"J Neuroimmunol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00205","article-title":"Tumor-specific T cell activation in malignant brain tumors","volume":"11","author":"Mohme M","year":"2020","unstructured":"Mohme M, Neidert MC. Tumor-specific T cell activation in malignant brain tumors. Front Immunol. 2020, 11:205. 10.3389\/fimmu.2020.00205","journal-title":"Front Immunol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-020-0183-x","article-title":"Revisiting the role of CD4+ T cells in cancer immunotherapy-new insights into old paradigms","volume":"28","author":"Tay RE","year":"2021","unstructured":"Tay RE, Richardson EK, Toh HC. Revisiting the role of CD4+ T cells in cancer immunotherapy-new insights into old paradigms. Cancer Gene Ther. 2021, 28:5-17. 10.1038\/s41417-020-0183-x","journal-title":"Cancer Gene Ther"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00991","article-title":"Immunological bases of paraneoplastic cerebellar degeneration and therapeutic implications","volume":"11","author":"Yshii L","year":"2020","unstructured":"Yshii L, Bost C, Liblau R. Immunological bases of paraneoplastic cerebellar degeneration and therapeutic implications. Front Immunol. 2020, 11:991. 10.3389\/fimmu.2020.00991","journal-title":"Front Immunol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2010.08.019","article-title":"Recent insights into the role and molecular mechanisms of the autoimmune regulator (AIRE) gene in autoimmunity","volume":"10","author":"Fierabracci A","year":"2011","unstructured":"Fierabracci A. Recent insights into the role and molecular mechanisms of the autoimmune regulator (AIRE) gene in autoimmunity. Autoimmun Rev. 2011, 10:137-43. 10.1016\/j.autrev.2010.08.019","journal-title":"Autoimmun Rev"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14069","article-title":"Regulatory T (Treg) cells in cancer: can Treg cells be a new therapeutic target?","volume":"110","author":"Ohue Y","year":"2019","unstructured":"Ohue Y, Nishikawa H. Regulatory T (Treg) cells in cancer: can Treg cells be a new therapeutic target?. Cancer Sci. 2019, 110:2080-9. 10.1111\/cas.14069","journal-title":"Cancer Sci"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.642800","article-title":"Paraneoplastic neurological syndromes and beyond emerging with the introduction of immune checkpoint inhibitor cancer immunotherapy","volume":"12","author":"Valencia-Sanchez C","year":"2021","unstructured":"Valencia-Sanchez C, Zekeridou A. Paraneoplastic neurological syndromes and beyond emerging with the introduction of immune checkpoint inhibitor cancer immunotherapy. Front Neurol. 2021, 12:642800. 10.3389\/fneur.2021.642800","journal-title":"Front Neurol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww225","article-title":"CTLA4 blockade elicits paraneoplastic neurological disease in a mouse model","volume":"139","author":"Yshii LM","year":"2016","unstructured":"Yshii LM, Gebauer CM, Pignolet B, et al.. CTLA4 blockade elicits paraneoplastic neurological disease in a mouse model. Brain. 2016, 139:2923-34. 10.1093\/brain\/aww225","journal-title":"Brain"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-019-0642-9","article-title":"Identification of a monoclonal antibody that targets PD-1 in a manner requiring PD-1 Asn58 glycosylation","volume":"2","author":"Wang M","year":"2019","unstructured":"Wang M, Wang J, Wang R, Jiao S, Wang S, Zhang J, Zhang M. Identification of a monoclonal antibody that targets PD-1 in a manner requiring PD-1 Asn58 glycosylation. Commun Biol. 2019, 2:392. 10.1038\/s42003-019-0642-9","journal-title":"Commun Biol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/109797-an-etiological-investigation-of-paraneoplastic-cerebellar-degeneration-in-ovarian-cancer-patients-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:46:58Z","timestamp":1707508018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/109797-an-etiological-investigation-of-paraneoplastic-cerebellar-degeneration-in-ovarian-cancer-patients-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,6]]},"references-count":37,"URL":"https:\/\/doi.org\/10.7759\/cureus.31154","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,6]]}}}